This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simmons, A Articles by Nash, A A Search for Related Content PubMed PubMed Citation Articles by Simmons, A Articles by Nash, A A

 Previous Article  |  Next Article 

J Virol. 1984 December; 52(3): 816-821

Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease.

ABSTRACT

During the development of a zosteriform rash, which occurs after flank inoculation of BALB/c mice with herpes simplex virus, clinically normal skin becomes infected via nerve endings. This is analogous to the final step in the development of a recrudescent lesion, which may occur after reactivation of latent virus. Therefore, the zosteriform reaction has potential as a model with which to study the modification of such a recrudescent infection by immune processes. Using an adoptive transfer system, we confirmed that immune lymph node cells are potent in accelerating the clearance of virus from the primary site of replication (the inoculation site). This effect was T cell dependent. However, if injection of the same cell population was delayed until ganglionic infection was established, the appearance of the zosteriform rash was not prevented, and the virus titer recovered from the lower flank was not reduced. Immunoperoxidase studies showed that virus is at first highly localized to the epidermis after it emerges from nerves. As determined by conventional histology, little cellular infiltration was seen until clinical lesions were apparent. These observations indicate that recrudescent lesions appear in the presence of cell populations normally associated with rapid virus clearance; cellular immune mechanisms may be rendered ineffective owing to the lack of recruitment to the site of recrudescence until tissue breakdown instigates an inflammatory response.

This article has been cited by other articles:

• Mintern, J. D., Guillonneau, C., Carbone, F. R., Doherty, P. C., Turner, S. J. (2007). Cutting Edge: Tissue-Resident Memory CTL Down-Regulate Cytolytic Molecule Expression following Virus Clearance. J. Immunol. 179: 7220-7224 [Abstract] [Full Text]  
• Pomeranz, L. E., Reynolds, A. E., Hengartner, C. J. (2005). Molecular Biology of Pseudorabies Virus: Impact on Neurovirology and Veterinary Medicine. Microbiol. Mol. Biol. Rev. 69: 462-500 [Abstract] [Full Text]  
• Brittle, E. E., Reynolds, A. E., Enquist, L. W. (2004). Two Modes of Pseudorabies Virus Neuroinvasion and Lethality in Mice. J. Virol. 78: 12951-12963 [Abstract] [Full Text]  
• van Lint, A., Ayers, M., Brooks, A. G., Coles, R. M., Heath, W. R., Carbone, F. R. (2004). Herpes Simplex Virus-Specific CD8+ T Cells Can Clear Established Lytic Infections from Skin and Nerves and Can Partially Limit the Early Spread of Virus after Cutaneous Inoculation. J. Immunol. 172: 392-397 [Abstract] [Full Text]  
• Judson, K. A., Lubinski, J. M., Jiang, M., Chang, Y., Eisenberg, R. J., Cohen, G. H., Friedman, H. M. (2003). Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection. J. Virol. 77: 12639-12645 [Abstract] [Full Text]  
• Connolly, S. A., Landsburg, D. J., Carfi, A., Wiley, D. C., Cohen, G. H., Eisenberg, R. J. (2003). Structure-Based Mutagenesis of Herpes Simplex Virus Glycoprotein D Defines Three Critical Regions at the gD-HveA/HVEM Binding Interface. J. Virol. 77: 8127-8140 [Abstract] [Full Text]  
• Elson, K., Speck, P., Simmons, A. (2003). Herpes simplex virus infection of murine sensory ganglia induces proliferation of neuronal satellite cells. J. Gen. Virol. 84: 1079-1084 [Abstract] [Full Text]  
• Grubor-Bauk, B., Simmons, A., Mayrhofer, G., Speck, P. G. (2003). Impaired Clearance of Herpes Simplex Virus Type 1 From Mice Lacking CD1d or NKT Cells Expressing the Semivariant V{alpha}14-J{alpha}281 TCR. J. Immunol. 170: 1430-1434 [Abstract] [Full Text]  
• Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., Vandepapeliere, P., Dubin, G., the GlaxoSmithKline Herpes Vaccine Efficacy Study, (2002). Glycoprotein-D-Adjuvant Vaccine to Prevent Genital Herpes. NEJM 347: 1652-1661 [Abstract] [Full Text]  
• Lubinski, J. M., Jiang, M., Hook, L., Chang, Y., Sarver, C., Mastellos, D., Lambris, J. D., Cohen, G. H., Eisenberg, R. J., Friedman, H. M. (2002). Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo. J. Virol. 76: 9232-9241 [Abstract] [Full Text]  
• Betz, U. A. K., Fischer, R., Kleymann, G., Hendrix, M., Rubsamen-Waigmann, H. (2002). Potent In Vivo Antiviral Activity of the Herpes Simplex Virus Primase-Helicase Inhibitor BAY 57-1293. Antimicrob. Agents Chemother. 46: 1766-1772 [Abstract] [Full Text]  
• Mueller, S. N., Jones, C. M., Smith, C. M., Heath, W. R., Carbone, F. R. (2002). Rapid Cytotoxic T Lymphocyte Activation Occurs in the Draining Lymph Nodes After Cutaneous Herpes Simplex Virus Infection as a Result of Early Antigen Presentation and Not the Presence of Virus. J. Exp. Med. 195: 651-656 [Abstract] [Full Text]  
• Summers, B. C., Margolis, T. P., Leib, D. A. (2001). Herpes Simplex Virus Type 1 Corneal Infection Results in Periocular Disease by Zosteriform Spread. J. Virol. 75: 5069-5075 [Abstract] [Full Text]  
• Pereira, R. A., Scalzo, A., Simmons, A. (2001). Cutting Edge: A NK Complex-Linked Locus Governs Acute Versus Latent Herpes Simplex Virus Infection of Neurons. J. Immunol. 166: 5869-5873 [Abstract] [Full Text]  
• Kurokawa, M., Hozumi, T., Tsurita, M., Kadota, S., Namba, T., Shiraki, K. (2001). Biological Characterization of Eugeniin as an Anti-Herpes Simplex Virus Type 1 Compound in Vitro and in Vivo. J. Pharmacol. Exp. Ther. 297: 372-379 [Abstract] [Full Text]  
• Abendroth, A., Simmons, A., Efstathiou, S., Pereira, R. A. (2000). Infection with an H2 recombinant herpes simplex virus vector results in expression of MHC class I antigens on the surfaces of human neuroblastoma cells in vitro and mouse sensory neurons in vivo. J. Gen. Virol. 81: 2375-2383 [Abstract] [Full Text]  
• Saldanha, C. E., Lubinski, J., Martin, C., Nagashunmugam, T., Wang, L., van der Keyl, H., Tal-Singer, R., Friedman, H. M. (2000). Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease. J. Virol. 74: 6712-6719 [Abstract] [Full Text]  
• Nash, A. A. (2000). T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation. J. Exp. Med. 191: 1455-1458 [Full Text]  
• Piret, J., Désormeaux, A., Gourde, P., Juhász, J., Bergeron, M. G. (2000). Efficacies of Topical Formulations of Foscarnet and Acyclovir and of 5-Percent Acyclovir Ointment (Zovirax) in a Murine Model of Cutaneous Herpes Simplex Virus Type 1 Infection. Antimicrob. Agents Chemother. 44: 30-38 [Abstract] [Full Text]  
• Pereira, R. A., Simon, M. M., Simmons, A. (2000). Granzyme A, a Noncytolytic Component of CD8+ Cell Granules, Restricts the Spread of Herpes Simplex Virus in the Peripheral Nervous Systems of Experimentally Infected Mice. J. Virol. 74: 1029-1032 [Abstract] [Full Text]  
• Lubinski, J., Wang, L., Mastellos, D., Sahu, A., Lambris, J. D., Friedman, H. M. (1999). In Vivo Role of Complement-interacting Domains of Herpes Simplex Virus Type 1 Glycoprotein gC. J. Exp. Med. 190: 1637-1646 [Abstract] [Full Text]  
• Pereira, R. A., Simmons, A. (1999). Cell Surface Expression of H2 Antigens on Primary Sensory Neurons in Response to Acute but Not Latent Herpes Simplex Virus Infection In Vivo. J. Virol. 73: 6484-6489 [Abstract] [Full Text]  
• Lubinski, J. M., Wang, L., Soulika, A. M., Burger, R., Wetsel, R. A., Colten, H., Cohen, G. H., Eisenberg, R. J., Lambris, J. D., Friedman, H. M. (1998). Herpes Simplex Virus Type 1 Glycoprotein gC Mediates Immune Evasion In Vivo. J. Virol. 72: 8257-8263 [Abstract] [Full Text]  
• Nagashunmugam, T., Lubinski, J., Wang, L., Goldstein, L. T., Weeks, B. S., Sundaresan, P., Kang, E. H., Dubin, G., Friedman, H. M. (1998). In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor. J. Virol. 72: 5351-5359 [Abstract] [Full Text]  
• Milligan, G. N., Bernstein, D. I., Bourne, N. (1998). T Lymphocytes Are Required for Protection of the Vaginal Mucosae and Sensory Ganglia of Immune Mice Against Reinfection with Herpes Simplex Virus Type 2. J. Immunol. 160: 6093-6100 [Abstract] [Full Text]  
• Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B. A., Catton, D. J., Hsu, D., Mittelstaedt, D., McCormack, J. E., Karavodin, L., Dubensky, T. W. Jr., Chang, S. M. W., Banks, T. A. (1998). DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector. J. Virol. 72: 950-958 [Abstract] [Full Text]  
• Peng, T., Ponce-de-Leon, M., Jiang, H., Dubin, G., Lubinski, J. M., Eisenberg, R. J., Cohen, G. H. (1998). The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge. J. Virol. 72: 65-72 [Abstract] [Full Text]